Exact Mass: 353.0616

Exact Mass Matches: 353.0616

Found 203 metabolites which its exact mass value is equals to given mass value 353.0616, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pentoxazone

Pentoxazone

C17H17ClFNO4 (353.083)


Precursor ion, [M-H]-, is a 37Cl-isotopolog ion.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.

   

2,5-diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one

{[(2R,3S,4R,5R)-5-[(2,5-diamino-6-oxo-1,6-dihydropyrimidin-4-yl)amino]-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C9H16N5O8P (353.0736)


2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone is a member of the class of compounds known as pentose phosphates. Pentose phosphates are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. 2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone can be found in a number of food items such as horned melon, buffalo currant, papaya, and red algae, which makes 2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone a potential biomarker for the consumption of these food products. 2,5-diamino-6-(5-phosphoribosylamino)-4-pyrimidineone exists in E.coli (prokaryote) and yeast (eukaryote).

   

Rugosinone

1,3-Dioxolo[4,5-g]isoquinolin-5-yl(2-hydroxy-3,4-dimethoxyphenyl)methanone

C19H15NO6 (353.0899)


   
   

2-((4-Methoxy-3-methyl-2-pyridylmethyl)sulfo)-5-trifluoromethyl-1H-benzimidazole

2-{[(4-methoxy-3-methylpyridin-2-yl)methyl]sulphanyl}-6-(trifluoromethyl)-1H-1,3-benzodiazole

C16H14F3N3OS (353.081)


   

Naphthol AS-D chloroacetate

2-(O-Tolylcarbamoyl)naphthalen-3-yl 2-chloroacetate

C20H16ClNO3 (353.0819)


   

Sambucus nigra Degraded cyanogenic glycosides (2'-Epimer)

Methyl 3-[(S)-cyano(phenyl)methoxy]-2-hydroxy-3-[(3-hydroxy-1-methoxy-1-oxopropan-2-yl)oxy]propanoic acid

C16H19NO8 (353.1111)


Sambucus nigra Degraded cyanogenic glycosides (2-Epimer) is found in fruits. Sambucus nigra Degraded cyanogenic glycosides (2-Epimer) is isolated from Sambucus nigra (elderberry Isolated from Sambucus nigra (elderberry). Sambucus nigra Degraded cyanogenic glycosides (2-Epimer) is found in fruits.

   

4-[(4'-O-Acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

(2S,3R,4S,5R,6S)-4,5-dihydroxy-6-[4-(isothiocyanatomethyl)phenoxy]-2-methyloxan-3-yl acetate

C16H19NO6S (353.0933)


4-[(4-O-Acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate is a glucosinolate that has been isolated from the seeds and leaves of Moringa oleifera (horseradish tree) and the seeds of Moringa peregrina. It is also found in herbs and spices. Constituent of seeds of Moringa oleifera (horseradish tree) and Moringa peregrina. 4-Hydroxybenzyl isothiocyanate 4-acetylrhamnoside is found in herbs and spices.

   

6'-O-Acetylholocalin

{6-[cyano(3-hydroxyphenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl acetic acid

C16H19NO8 (353.1111)


6-O-Acetylholocalin is found in fruits. 6-O-Acetylholocalin is a constituent of Sambucus nigra (elderberry) Constituent of Sambucus nigra (elderberry). 6-O-Acetylholocalin is found in fruits.

   

Acenocoumarol

4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one

C19H15NO6 (353.0899)


Acenocoumarol is a coumarin derivative used as an anticoagulant. Coumarin derivatives inhibit the reduction of vitamin K by vitamin K reductase. This prevents carboxylation of vitamin K-dependent clotting factors, II, VII, XI and X, and interferes with coagulation. Hematocrit, hemoglobin, international normalized ratio and liver panel should be monitored. Patients on acenocoumarol are prohibited from giving blood. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

5'-Hydroxytenoxicam

(3Z)-3-{hydroxy[(5-hydroxypyridin-2-yl)amino]methylidene}-2-methyl-2H,3H,4H-1λ⁶-thieno[2,3-e][1,2]thiazine-1,1,4-trione

C13H11N3O5S2 (353.014)


5-Hydroxytenoxicam is only found in individuals that have used or taken Tenoxicam. 5-Hydroxytenoxicam is a metabolite of Tenoxicam. 5-hydroxytenoxicam belongs to the family of Thienothiazines. These are heterocyclic compounds containing a thiophene ring fused to a thiazine.

   

4'-Hydroxy-5-carboxy-lumiracoxib

3-{[2-(carboxymethyl)-4-methylphenyl]amino}-4-chloro-2-fluoro-6-hydroxybenzoic acid

C16H13ClFNO5 (353.0466)


4-Hydroxy-5-carboxy-lumiracoxib is a metabolite of lumiracoxib. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as Prestige by the media). Lumiracoxib has several distinctive features. (Wikipedia)

   

lansoprazole sulfide

2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]-1-(methylsulfanyl)-1H-1,3-benzodiazole

C16H14F3N3OS (353.081)


lansoprazole sulfide is a metabolite of lansoprazole. Lansoprazole is a proton-pump inhibitor (PPI) which inhibits the stomachs production of gastric acids. It is manufactured by a number of companies worldwide under several brand names. In the United States it was first approved by the Food and Drug Administration (FDA) in 1995. Lansoprazole has been available as a generic drug since Prevacid patent protection expired on November 10, 2009. Since 2009 Lansoprazole has been available over the counter (OTC) in the U.S. (Wikipedia)

   

Naringenin 5-sulfate

{4-[7-hydroxy-4-oxo-5-(sulphooxy)-3,4-dihydro-2H-1-benzopyran-2-yl]phenyl}oxidanium

C15H13O8S (353.0331)


   

2-(O-Tolylcarbamoyl)naphthalen-3-yl 2-chloroacetate

3-[(2-methylphenyl)carbamoyl]naphthalen-2-yl 2-chloroacetate

C20H16ClNO3 (353.0819)


   

7-(3-Isothiocyanatopyrrolidin-1-yl)-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide

4-(3-Isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2,1,3-benzoxadiazole

C13H15N5O3S2 (353.0616)


   

Aceclofenac

2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid carboxymethyl ester

C16H13Cl2NO4 (353.0222)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Clopidogrel thiol

Methyl 2-(2-chlorophenyl)-2-sulphanyl-2-{4h,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetic acid

C16H16ClNO2S2 (353.0311)


   

Daltroban

2-[4-[2-[(4-Chlorophenyl)sulphonylamino]ethyl]phenyl]acetic acid

C16H16ClNO4S (353.0489)


   

Englitazone

5-((3,4-Dihydro-2-phenylmethyl-2H-1-benzopyran-6-yl)methyl)thiazolidine-2,4-dione

C20H19NO3S (353.1086)


   

Flosulide

N-[6-(2,4-difluorophenoxy)-1-oxo-2,3-dihydro-1H-inden-5-yl]methanesulfonamide

C16H13F2NO4S (353.0533)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

4-(4'-Chlorobenzyloxy)benzyl nicotinate

{4-[(4-chlorophenyl)methoxy]phenyl}methyl pyridine-3-carboxylate

C20H16ClNO3 (353.0819)


   

Syk Inhibitor

3-[(1-Methyl-1H-indol-3-yl)methylidene]-2-oxo-2,3-dihydro-1H-indole-5-sulphonamide

C18H15N3O3S (353.0834)


   

3,4-Dioxosarcocapnidine

3,4-Dioxosarcocapnidine

C19H15NO6 (353.0899)


   

9-Methoxyaristolactam IV

9-Methoxyaristolactam IV

C19H15NO6 (353.0899)


   

Diethyl 3-methyl-5-[(trifluoroacetyl)amino]-2,4-thiophenedicarboxylate

Diethyl 3-methyl-5-[(trifluoroacetyl)amino]-2,4-thiophenedicarboxylate

C13H14F3NO5S (353.0545)


   

Maybridge4_001340

Maybridge4_001340

C15H15NO5S2 (353.0392)


   

Aceclofenac

Aceclofenac

C16H13Cl2NO4 (353.0222)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents CONFIDENCE standard compound; INTERNAL_ID 1161

   

Pyrazolam

Pyrazolam

C16H12BrN5 (353.0276)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators

   
   

5-Hydroxytenoxicam

5-Hydroxytenoxicam

C13H11N3O5S2 (353.014)


   

N-(2-Cyanoethyl)-N-(2-thienylmethyl)-N-[3-(trifluoromethyl)phenyl]urea

N-(2-Cyanoethyl)-N-(2-thienylmethyl)-N-[3-(trifluoromethyl)phenyl]urea

C16H14F3N3OS (353.081)


   

PharmaGSID_48505

PharmaGSID_48505

C17H12ClN5O2 (353.0679)


CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4766; ORIGINAL_PRECURSOR_SCAN_NO 4764 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4776; ORIGINAL_PRECURSOR_SCAN_NO 4773 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4805; ORIGINAL_PRECURSOR_SCAN_NO 4803 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4769; ORIGINAL_PRECURSOR_SCAN_NO 4767 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4827; ORIGINAL_PRECURSOR_SCAN_NO 4826 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9149; ORIGINAL_PRECURSOR_SCAN_NO 9147 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9178; ORIGINAL_PRECURSOR_SCAN_NO 9177 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9199; ORIGINAL_PRECURSOR_SCAN_NO 9197 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9243; ORIGINAL_PRECURSOR_SCAN_NO 9240 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9252; ORIGINAL_PRECURSOR_SCAN_NO 9247 CONFIDENCE standard compound; INTERNAL_ID 484; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9252; ORIGINAL_PRECURSOR_SCAN_NO 9249

   
   

[4-(3-O-acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

[4-(3-O-acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

C16H19NO6S (353.0933)


   
   

7,8,10-Trimethoxybenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one

7,8,10-Trimethoxybenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one

C19H15NO6 (353.0899)


   

2,3:9,10-Bis(methylenedioxy)-5,6-dihydro-8H-dibenzo[a,g]quinolizine-1,8-diol

2,3:9,10-Bis(methylenedioxy)-5,6-dihydro-8H-dibenzo[a,g]quinolizine-1,8-diol

C19H15NO6 (353.0899)


   

[4-(2-O-acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

[4-(2-O-acetyl-alpha-L-rhamnosyloxy)benzyl]isothiocyanate

C16H19NO6S (353.0933)


   

(+/-)-linaresine|(??)-Linaresine|8,9-dimethoxy-6,7-methylenedioxy-12H<1>benzoxepino<2,3,4-ij>isoquinolin-12-ol|linaresinen

(+/-)-linaresine|(??)-Linaresine|8,9-dimethoxy-6,7-methylenedioxy-12H<1>benzoxepino<2,3,4-ij>isoquinolin-12-ol|linaresinen

C19H15NO6 (353.0899)


   

(6-O-beta-D-glucopyranosyl-1H-indol-3-yl) carboxylic acid methyl ester

(6-O-beta-D-glucopyranosyl-1H-indol-3-yl) carboxylic acid methyl ester

C16H19NO8 (353.1111)


   

7-methoxy-aristololactam IV

7-methoxy-aristololactam IV

C19H15NO6 (353.0899)


   

adlumidine|bicucculine|D-bicucculine

adlumidine|bicucculine|D-bicucculine

C19H15NO6 (353.0899)


   

(-)-Eudistomin K|Eudistomin K|eudistomin K trifluoroacetate

(-)-Eudistomin K|Eudistomin K|eudistomin K trifluoroacetate

C14H16BrN3OS (353.0197)


   

dichotomide V

dichotomide V

C18H15N3O5 (353.1012)


A beta-carboline alkaloid isolated from Stellaria dichotoma var. lanceolata.

   
   

1-(2-oxindole-3-acetyl)-beta-D-glucose

1-(2-oxindole-3-acetyl)-beta-D-glucose

C16H19NO8 (353.1111)


An O-acyl carbohydrate obtained by formal condensation of the carboxy group of 2-oxindole-3-acetic acid with the anomeric hydroxy group of beta-D-glucose.

   

(S)-Acenocoumarol

4-hydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one

C19H15NO6 (353.0899)


The (R)-enantiomer of acenocoumarol. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists A hydroxycoumarin that is warfarin in which the hydrogen at position 4 of the phenyl substituent is replaced by a nitro group. D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   
   
   
   
   
   
   
   
   

Famotidine sulfoxide

3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]sulfinyl]-N-(aminosulfonyl)propanimidamide

C8H15N7O3S3 (353.0398)


   

H 152/66

Clevidipine Impurity 7

C16H13Cl2NO4 (353.0222)


   
   

2-Hydroxytenoxicam

2-Hydroxytenoxicam

C13H11N3O5S2 (353.014)


   

Cyclopenta[c]pyrrole, benzoic acid deriv

Cyclopenta[c]pyrrole, benzoic acid deriv

C15H19N3O5S (353.1045)


   

4-Hydroxybenzyl isothiocyanate 4''-acetylrhamnoside

4,5-dihydroxy-6-[4-(isothiocyanatomethyl)phenoxy]-2-methyloxan-3-yl acetate

C16H19NO6S (353.0933)


   

Sambucus nigra degraded cyanogenic glycosides

methyl 3-[cyano(phenyl)methoxy]-2-hydroxy-3-[(3-hydroxy-1-methoxy-1-oxopropan-2-yl)oxy]propanoate

C16H19NO8 (353.1111)


   

6''-O-Acetylholocalin

{6-[cyano(3-hydroxyphenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl acetate

C16H19NO8 (353.1111)


   

Lansoprazole Sulfide

Lansoprazole Sulfide

C16H14F3N3OS (353.081)


   

2-[1-(4-methoxyphenyl)-4-nitro-3-thiophen-2-ylbutylidene]propanedinitrile

2-[1-(4-methoxyphenyl)-4-nitro-3-thiophen-2-ylbutylidene]propanedinitrile

C18H15N3O3S (353.0834)


   

1-(6-Chloro-9H-purin-9-yl)-1-deoxy-N-methyl-2,3-O-isopropylidene-beta-D-ribofuranuronamide

1-(6-Chloro-9H-purin-9-yl)-1-deoxy-N-methyl-2,3-O-isopropylidene-beta-D-ribofuranuronamide

C14H16ClN5O4 (353.0891)


   

4-[[4-(dimethylamino)phenyl]carbamoylamino]benzenesulfonyl chloride

4-[[4-(dimethylamino)phenyl]carbamoylamino]benzenesulfonyl chloride

C15H16ClN3O3S (353.0601)


   

2-(2-CHLORO-ACETYLAMINO)-4-(4-METHOXY-PHENYL)-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

2-(2-CHLORO-ACETYLAMINO)-4-(4-METHOXY-PHENYL)-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER

C16H16ClNO4S (353.0489)


   

Thiazolidine, 3-[(4-chlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(4-chlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C16H16ClNO2S2 (353.0311)


   

(S)-(+)-ALPHA-METHYL-1H-IMIDAZOLE-4-ETHANAMINEDIHYDROBROMIDE

(S)-(+)-ALPHA-METHYL-1H-IMIDAZOLE-4-ETHANAMINEDIHYDROBROMIDE

C13H15N5O3S2 (353.0616)


   

(1Z)-4-chloro-3-sulfamoyl-N-(2,4,6-trimethylpyridin-1-ium-1-yl)benzenecarboximidate

(1Z)-4-chloro-3-sulfamoyl-N-(2,4,6-trimethylpyridin-1-ium-1-yl)benzenecarboximidate

C15H16ClN3O3S (353.0601)


   

4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide

4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide

C13H15N5O3S2 (353.0616)


   

n-bsmoc-l-leucine

n-bsmoc-l-leucine

C16H19NO6S (353.0933)


   

n-bsmoc-l-isoleucine

n-bsmoc-l-isoleucine

C16H19NO6S (353.0933)


   

Buthiazide

Buthiazide

C11H16ClN3O4S2 (353.0271)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

4-[3-(4-CARBAMOYL-PHENYL)UREIDO]BENZENESULFONYLCHLORIDE

4-[3-(4-CARBAMOYL-PHENYL)UREIDO]BENZENESULFONYLCHLORIDE

C14H12ClN3O4S (353.0237)


   

4-((2-AMINOPHENYL)THIO)-N,N-DIMETHYL-3-NITROBENZENESULFONAMIDE

4-((2-AMINOPHENYL)THIO)-N,N-DIMETHYL-3-NITROBENZENESULFONAMIDE

C14H15N3O4S2 (353.0504)


   

(-)-TRANS-MYRTANYLACETATE

(-)-TRANS-MYRTANYLACETATE

C9H9F6N3O3S (353.0269)


   

Diethyl thiophosphoril (Z)-(2-aminothiazol-4-yl)-(methoxyimino)acetate

Diethyl thiophosphoril (Z)-(2-aminothiazol-4-yl)-(methoxyimino)acetate

C10H16N3O5PS2 (353.0269)


   

OXSI-2

Syk Inhibitor

C18H15N3O3S (353.0834)


   
   

(2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(2-NITROPHENOXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID

(2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(2-NITROPHENOXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID

C12H12KNO9 (353.0149)


   

4-(Phenylamino)-3-sulfoazobenzene

3-[(4-anilinophenyl)azo]benzenesulphonic acid

C18H15N3O3S (353.0834)


   

Side chain for meropenem

Side chain for meropenem

C15H19N3O5S (353.1045)


   

2-Butenoic acid,4-oxo-4-[[4-[(2-thiazolylamino)sulfonyl]phenyl]amino]-, (2Z)-

2-Butenoic acid,4-oxo-4-[[4-[(2-thiazolylamino)sulfonyl]phenyl]amino]-, (2Z)-

C13H11N3O5S2 (353.014)


   
   

2-Methyl-2-propanyl 5-bromo-3-[(dimethylamino)methyl]-1H-pyrrolo[ 2,3-b]pyridine-1-carboxylate

2-Methyl-2-propanyl 5-bromo-3-[(dimethylamino)methyl]-1H-pyrrolo[ 2,3-b]pyridine-1-carboxylate

C15H20BrN3O2 (353.0739)


   

naphthol as-tr acetate

naphthol as-tr acetate

C20H16ClNO3 (353.0819)


   

p-aminophenylmercuric acetate

p-aminophenylmercuric acetate

C8H9HgNO2 (353.034)


   

Quinfamide

Quinfamide

C16H13Cl2NO4 (353.0222)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

4-[(3,3-Dimethylbutanoyl)amino]-3,5-difluoro-N-(1,3-thiazol-2-yl) benzamide

4-[(3,3-Dimethylbutanoyl)amino]-3,5-difluoro-N-(1,3-thiazol-2-yl) benzamide

C16H17F2N3O2S (353.1009)


   

ethyl 2-piperazine-4-(2,5-difluoro)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(2,5-difluoro)phenyl thiazole-5-carboxylate

C16H17F2N3O2S (353.1009)


   

FPH2

4-(3-(5-Chloro-2-methoxyphenyl)thioureido)-1-ethyl-1H-pyrazole-3-carboxamide

C14H16ClN5O2S (353.0713)


   

5,7-BIS(TRIFLUOROMETHYL)-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

5,7-BIS(TRIFLUOROMETHYL)-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

C14H9F6NO3 (353.0487)


   

1,3-dimethyl-6-[2-(p-toluenesulfonyloxy)ethylamino)-2,4(1H,3H)-pyrimidinedione

1,3-dimethyl-6-[2-(p-toluenesulfonyloxy)ethylamino)-2,4(1H,3H)-pyrimidinedione

C15H19N3O5S (353.1045)


   

bis(triphenylphosphine)iminium nitrite

bis(triphenylphosphine)iminium nitrite

[(C6H5)3P=]2N(ONO) (353.0609)


   
   

4-[6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid

4-[6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid

C16H20ClN3O2S (353.0965)


   

AcenocouMarol-d4

AcenocouMarol-d4

C19H15NO6 (353.0899)


   

Daltroban

Daltroban

C16H16ClNO4S (353.0489)


D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C26170 - Protective Agent > C2079 - Cardioprotective Agent

   

2-DEOXYADENOSINE 3-MONOPHOSPHATE SODIUM SALT

2-DEOXYADENOSINE 3-MONOPHOSPHATE SODIUM SALT

C10H13N5NaO6P (353.0501)


   

N7-(3-CHLOROPHENYL)-N2-PHENYLTHIAZOLO[5,4-D]PYRIMIDINE-2,7-DIAMINE

N7-(3-CHLOROPHENYL)-N2-PHENYLTHIAZOLO[5,4-D]PYRIMIDINE-2,7-DIAMINE

C17H12ClN5S (353.0502)


   

4-CHLORO-2-TRIFLUOROACETYL-6-(TERT-BUTYLDIMETHYLSILYLOXY)ANILINE

4-CHLORO-2-TRIFLUOROACETYL-6-(TERT-BUTYLDIMETHYLSILYLOXY)ANILINE

C14H19ClF3NO2Si (353.0826)


   

2-[2-chloro-5-(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)-4-fluoro-phe noxy]acetic acid

2-[2-chloro-5-(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)-4-fluoro-phe noxy]acetic acid

C16H13ClFNO5 (353.0466)


   

3-(4-ACETOXY-PHENYL)-2-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONIC ACID

3-(4-ACETOXY-PHENYL)-2-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PROPIONIC ACID

C19H15NO6 (353.0899)


   

tris(cyclopentadienyl)gadolinium

tris(cyclopentadienyl)gadolinium

C15H15Gd (353.0415)


   

3,6-Diamino-5-cyano-4-(4-ethoxyphenyl)thieno[2,3-b]pyridine-2-carboxamide

3,6-Diamino-5-cyano-4-(4-ethoxyphenyl)thieno[2,3-b]pyridine-2-carboxamide

C17H15N5O2S (353.0946)


   

6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine

6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine

C19H16FN3OS (353.0998)


   

Dabuzalgron hydrochloride

Dabuzalgron hydrochloride

C12H17Cl2N3O3S (353.0368)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

2-oxindole-3-acetyl-beta-D-glucose

2-oxindole-3-acetyl-beta-D-glucose

C16H19NO8 (353.1111)


   

(S)-2-amino-4-(4-((3,4-dichlorobenzyl)oxy)phenyl)-2-methylbutan-1-ol

(S)-2-amino-4-(4-((3,4-dichlorobenzyl)oxy)phenyl)-2-methylbutan-1-ol

C18H21Cl2NO2 (353.0949)


P053 is a potent, non-competitive and selective ceramide synthase 1 (CerS1) inhibitor wirh an IC50 of 0.5?μM. P053 acts as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle. Whole-body adiposity regulator[1].

   

1-methylsulfanyl-2-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]benzimidazole;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole

1-methylsulfanyl-2-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]benzimidazole;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole

C16H14F3N3OS (353.081)


   

Glionitrin A

Glionitrin A

C13H11N3O5S2 (353.014)


A pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring. It is an antibiotic isolated from the microbial strains Sphingomonas and Aspergillus fumigatus, and exhibits cytotoxic activity against four human cancer cell lines: HCT-116, A549, AGS, and DU145. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines

   

9-Hydroxyiminofluorene-2,7-disulfonamide

9-Hydroxyiminofluorene-2,7-disulfonamide

C13H11N3O5S2 (353.014)


   

3-(2-Pyrimidinylthio)-1-[2-(trifluoromethyl)phenyl]pyrrolidine-2,5-dione

3-(2-Pyrimidinylthio)-1-[2-(trifluoromethyl)phenyl]pyrrolidine-2,5-dione

C15H10F3N3O2S (353.0446)


   

7,9-dimethyl-2-(phenylmethylthio)-1H-pyrido[2,3]thieno[2,4-b]pyrimidin-4-one

7,9-dimethyl-2-(phenylmethylthio)-1H-pyrido[2,3]thieno[2,4-b]pyrimidin-4-one

C18H15N3OS2 (353.0656)


   

2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-(dimethylamino)-1,3-oxazole-4-carbonitrile

2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-(dimethylamino)-1,3-oxazole-4-carbonitrile

C19H16ClN3O2 (353.0931)


   

2-chloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

2-chloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

C19H16ClN3O2 (353.0931)


   

2,4-Thiazolidinedione, 5-((3,4-dihydro-2-(phenylmethyl)-2H-1-benzopyran-6-yl)methyl)-

2,4-Thiazolidinedione, 5-((3,4-dihydro-2-(phenylmethyl)-2H-1-benzopyran-6-yl)methyl)-

C20H19NO3S (353.1086)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent D007004 - Hypoglycemic Agents

   

2H-Thieno(2,3-e)-1,2-thiazine-3-carboxamide, 4-hydroxy-N-(5-hydroxy-2-pyridinyl)-2-methyl-, 1,1-dioxide

2H-Thieno(2,3-e)-1,2-thiazine-3-carboxamide, 4-hydroxy-N-(5-hydroxy-2-pyridinyl)-2-methyl-, 1,1-dioxide

C13H11N3O5S2 (353.014)


   

Chlorogenate anion

Chlorogenate anion

C16H17O9- (353.0873)


   

5-(Hydroxymethyl)cytidine 5-(Dihydrogen Phosphate)

5-(Hydroxymethyl)cytidine 5-(Dihydrogen Phosphate)

C10H16N3O9P (353.0624)


   

2,5-diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5-phosphate(2-)

2,5-diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5-phosphate(2-)

C9H16N5O8P-2 (353.0736)


   

3-(2,4-Dihydroxyphenyl)-7-hydroxy-6-(3-methylbut-2-enyl)-4-oxochromen-5-olate

3-(2,4-Dihydroxyphenyl)-7-hydroxy-6-(3-methylbut-2-enyl)-4-oxochromen-5-olate

C20H17O6- (353.1025)


   

3-Prenyl-5,7,2,4-tetrahydroxyisoflavone

3-Prenyl-5,7,2,4-tetrahydroxyisoflavone

C20H17O6- (353.1025)


   

3-(2,4-Dihydroxyphenyl)-5-hydroxy-8-(3-methylbut-2-enyl)-4-oxochromen-7-olate

3-(2,4-Dihydroxyphenyl)-5-hydroxy-8-(3-methylbut-2-enyl)-4-oxochromen-7-olate

C20H17O6- (353.1025)


   

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(methyldisulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(methyldisulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C11H19N3O6S2 (353.0715)


   

anthraquinone-2-carboxyate-N-acetylcysteamine

anthraquinone-2-carboxyate-N-acetylcysteamine

C19H15NO4S (353.0722)


   

a 2-Oxindole-3-acetyl-hexose

a 2-Oxindole-3-acetyl-hexose

C16H19NO8 (353.1111)


   

N-Acetyl-S-(2,6,7-trimethyl-3,5-dioxo-3H,5H-pyrazolo[1,2-a]pyrazol-1-ylmethyl)-L-cysteine

N-Acetyl-S-(2,6,7-trimethyl-3,5-dioxo-3H,5H-pyrazolo[1,2-a]pyrazol-1-ylmethyl)-L-cysteine

C15H19N3O5S (353.1045)


   

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[[3-(2-hydroxyethyl)-1H-indol-5-yl]oxy]oxane-2-carboxylic acid

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[[3-(2-hydroxyethyl)-1H-indol-5-yl]oxy]oxane-2-carboxylic acid

C16H19NO8 (353.1111)


   

Englitazone

Englitazone

C20H19NO3S (353.1086)


D007004 - Hypoglycemic Agents

   

methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)-2-sulfanylacetate

methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)-2-sulfanylacetate

C16H16ClNO2S2 (353.0311)


   

Naringenin 5-sulfate

Naringenin 5-sulfate

C15H13O8S+ (353.0331)


   

trans-5-O-caffeoyl-D-quinate

trans-5-O-caffeoyl-D-quinate

C16H17O9- (353.0873)


A hydroxy monocarboxylic acid anion that is the conjugate base of trans-5-O-caffeoyl-D-quinic acid; major species at pH 7.3.

   

1-(2,4-Difluorophenyl)-5-[[[methylamino(sulfanylidene)methyl]hydrazinylidene]methyl]-4-pyrazolecarboxylic acid methyl ester

1-(2,4-Difluorophenyl)-5-[[[methylamino(sulfanylidene)methyl]hydrazinylidene]methyl]-4-pyrazolecarboxylic acid methyl ester

C14H13F2N5O2S (353.0758)


   

1-[(E)-[5-(2,5-dichlorophenyl)furan-2-yl]methylideneamino]-3-prop-2-enylthiourea

1-[(E)-[5-(2,5-dichlorophenyl)furan-2-yl]methylideneamino]-3-prop-2-enylthiourea

C15H13Cl2N3OS (353.0156)


   

Methyl 2-[(4-chloro-1-methylpyrazole-3-carbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

Methyl 2-[(4-chloro-1-methylpyrazole-3-carbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C15H16ClN3O3S (353.0601)


   

1-[[2-(4-Chlorophenyl)-1-oxoethyl]amino]-3-(1-naphthalenyl)urea

1-[[2-(4-Chlorophenyl)-1-oxoethyl]amino]-3-(1-naphthalenyl)urea

C19H16ClN3O2 (353.0931)


   

Glu-Cys-Cys

Glu-Cys-Cys

C11H19N3O6S2 (353.0715)


A tripeptide composed of one L-glutamic acid and two L-cysteine units joined by peptide linkages.

   

Cysteine tryptophylquinone

Cysteine tryptophylquinone

C14H15N3O6S (353.0682)


   

2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide

2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide

C14H16BrN3OS (353.0197)


   

2-[[(3,5-Dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid

2-[[(3,5-Dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid

C16H13Cl2NO4 (353.0222)


   

N-[(4-chlorophenyl)methyl]-4-(2-furanyl)-6-(trifluoromethyl)-2-pyrimidinamine

N-[(4-chlorophenyl)methyl]-4-(2-furanyl)-6-(trifluoromethyl)-2-pyrimidinamine

C16H11ClF3N3O (353.0543)


   

3-amino-N-(2-fluorophenyl)-6-(2-furanyl)-2-thieno[2,3-b]pyridinecarboxamide

3-amino-N-(2-fluorophenyl)-6-(2-furanyl)-2-thieno[2,3-b]pyridinecarboxamide

C18H12FN3O2S (353.0634)


   

3,4-didehydro-N(4)-deethylbrinzolamide

3,4-didehydro-N(4)-deethylbrinzolamide

C10H15N3O5S3 (353.0174)


   

3-[(3,5-Dichloro-4-ethoxybenzoyl)amino]benzoic acid

3-[(3,5-Dichloro-4-ethoxybenzoyl)amino]benzoic acid

C16H13Cl2NO4 (353.0222)


   

2-[(4,6-Dioxo-2-thioxo-tetrahydro-pyrimidin-5-ylidenemethyl)-amino]-5-ethyl-thiophene-3-carboxylic acid ethyl ester

2-[(4,6-Dioxo-2-thioxo-tetrahydro-pyrimidin-5-ylidenemethyl)-amino]-5-ethyl-thiophene-3-carboxylic acid ethyl ester

C14H15N3O4S2 (353.0504)


   

1-(3-Chlorophenyl)-3-[3-[methyl(methylsulfonyl)amino]phenyl]urea

1-(3-Chlorophenyl)-3-[3-[methyl(methylsulfonyl)amino]phenyl]urea

C15H16ClN3O3S (353.0601)


   

1-[1-(3-Chloro-4-fluorophenyl)-2,5-dioxo-3-pyrrolidinyl]-4-piperidinecarboxamide

1-[1-(3-Chloro-4-fluorophenyl)-2,5-dioxo-3-pyrrolidinyl]-4-piperidinecarboxamide

C16H17ClFN3O3 (353.0942)


   

1-(4-Chloro-2,5-dimethoxyphenyl)sulfonylbenzotriazole

1-(4-Chloro-2,5-dimethoxyphenyl)sulfonylbenzotriazole

C14H12ClN3O4S (353.0237)


   

1-(1-Azepanyl)-2-(2-bromo-4-propan-2-ylphenoxy)ethanone

1-(1-Azepanyl)-2-(2-bromo-4-propan-2-ylphenoxy)ethanone

C17H24BrNO2 (353.099)


   

5-(2-chlorophenyl)-2-(2-pyridinylmethyl)-3H-thieno[2,3-d]pyrimidin-4-one

5-(2-chlorophenyl)-2-(2-pyridinylmethyl)-3H-thieno[2,3-d]pyrimidin-4-one

C18H12ClN3OS (353.039)


   

4-Methoxybenzoic acid [2-oxo-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]ethyl] ester

4-Methoxybenzoic acid [2-oxo-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]ethyl] ester

C18H15N3O5 (353.1012)


   

ethyl (4Z)-2-methyl-1-(4-methylphenyl)-5-oxo-4-(thiophen-2-ylmethylidene)pyrrole-3-carboxylate

ethyl (4Z)-2-methyl-1-(4-methylphenyl)-5-oxo-4-(thiophen-2-ylmethylidene)pyrrole-3-carboxylate

C20H19NO3S (353.1086)


   
   
   

(2S)-2-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]-2-phenylacetamide

(2S)-2-amino-N-[4-chloro-2-[oxo(1H-pyrrol-2-yl)methyl]phenyl]-2-phenylacetamide

C19H16ClN3O2 (353.0931)


   
   
   
   
   
   
   

3-[(S)-[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfinyl]-N-sulfamoylpropanimidamide

3-[(S)-[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfinyl]-N-sulfamoylpropanimidamide

C8H15N7O3S3 (353.0398)


   

(E)-4-naphthalen-1-yl-2-oxo-3-quinolin-2-ylbut-3-enoic acid

(E)-4-naphthalen-1-yl-2-oxo-3-quinolin-2-ylbut-3-enoic acid

C23H15NO3 (353.1052)


   

3,4,5-trihydroxy-6-(4-hydroxy-1H-indole-3-carbonyl)oxyoxane-2-carboxylic acid

3,4,5-trihydroxy-6-(4-hydroxy-1H-indole-3-carbonyl)oxyoxane-2-carboxylic acid

C15H15NO9 (353.0747)


   

4H,5H-3-Methoxycarbonyl-4-(1-methoxycarbonylpyrrol-2-YL)methylene-1-phenylpyrazol-5-one

4H,5H-3-Methoxycarbonyl-4-(1-methoxycarbonylpyrrol-2-YL)methylene-1-phenylpyrazol-5-one

C18H15N3O5 (353.1012)


   

2,5-diamino-4-hydroxy-6-(5-phosphoribosylamino)pyrimidine

2,5-diamino-4-hydroxy-6-(5-phosphoribosylamino)pyrimidine

C9H16N5O8P (353.0736)


   

B 823-08

2-((4-Methoxy-3-methyl-2-pyridylmethyl)sulfo)-5-trifluoromethyl-1H-benzimidazole

C16H14F3N3OS (353.081)


   

6-O-Acetylholocalin

6-O-Acetylholocalin

C16H19NO8 (353.1111)


   

Sambucus nigra Degraded cyanogenic glycosides (2-Epimer)

Sambucus nigra Degraded cyanogenic glycosides (2-Epimer)

C16H19NO8 (353.1111)


   

4-Hydroxybenzyl isothiocyanate 4-acetylrhamnoside

4-Hydroxybenzyl isothiocyanate 4-acetylrhamnoside

C16H19NO6S (353.0933)


   

Chlorogenate

Chlorogenate

C16H17O9 (353.0873)


A monocarboxylic acid anion that is the conjugate base of chlorogenic acid; major species at pH 7.3.

   

2,5-Diamino-6-(1-D-ribosylamino)pyrimidin-4(3H)-one 5-phosphate

2,5-Diamino-6-(1-D-ribosylamino)pyrimidin-4(3H)-one 5-phosphate

C9H16N5O8P (353.0736)


5-O-Phosphono-beta-D-ribofuranose in which the hydroxy group at position 1 is substituted by the 6-amino group of 2,5,6-triaminopyrimidin-4(3H)-one.

   

2,5-diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5-phosphate(2-)

2,5-diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5-phosphate(2-)

C9H16N5O8P (353.0736)


The dianion resulting from the removal of two protons from the phosphate group of 2,5-diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5-phosphate.

   
   

UBP310

UBP310

C14H15N3O6S (353.0682)


UBP310 is a selective GluR5 antagonist, with a Kd of 130 nM[1].

   

15-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

15-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

C14H16BrN3OS (353.0197)


   

(2s,3r,4r,5r,6s)-4,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-3-yl acetate

(2s,3r,4r,5r,6s)-4,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-3-yl acetate

C16H19NO6S (353.0933)


   

(10s)-10-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8-trien-12-one

(10s)-10-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8-trien-12-one

C19H15NO6 (353.0899)


   

6-acetylholocalin

NA

C16H19NO8 (353.1111)


{"Ingredient_id": "HBIN012170","Ingredient_name": "6-acetylholocalin","Alias": "NA","Ingredient_formula": "C16H19NO8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "412","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

methyl (2r)-2-[(1r,2r)-1-[(s)-cyano(phenyl)methoxy]-2-hydroxy-3-methoxy-3-oxopropoxy]-3-hydroxypropanoate

methyl (2r)-2-[(1r,2r)-1-[(s)-cyano(phenyl)methoxy]-2-hydroxy-3-methoxy-3-oxopropoxy]-3-hydroxypropanoate

C16H19NO8 (353.1111)


   

3,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-4-yl acetate

3,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-4-yl acetate

C16H19NO6S (353.0933)


   

12,14,16-trimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

12,14,16-trimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

C19H15NO6 (353.0899)


   

methyl 3-({1-acetyl-8-hydroxy-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

methyl 3-({1-acetyl-8-hydroxy-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

C18H15N3O5 (353.1012)


   

(14r)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2(10),3,8,15,20,22-heptaene-3,14-diol

(14r)-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2(10),3,8,15,20,22-heptaene-3,14-diol

C19H15NO6 (353.0899)


   

(1s,11s)-11-(hydroxymethyl)-15-methyl-6-nitro-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

(1s,11s)-11-(hydroxymethyl)-15-methyl-6-nitro-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

C13H11N3O5S2 (353.014)


   

(2s,3s)-14-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

(2s,3s)-14-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

C14H16BrN3OS (353.0197)


   

(4s)-4-amino-4-{[(1r)-1-{[(1r)-1-carboxy-2-sulfanylethyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid

(4s)-4-amino-4-{[(1r)-1-{[(1r)-1-carboxy-2-sulfanylethyl]-c-hydroxycarbonimidoyl}-2-sulfanylethyl]-c-hydroxycarbonimidoyl}butanoic acid

C11H19N3O6S2 (353.0715)


   

14-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

14-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

C14H16BrN3OS (353.0197)


   

(2s,3r,4r,5s,6s)-3,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-4-yl acetate

(2s,3r,4r,5s,6s)-3,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-4-yl acetate

C16H19NO6S (353.0933)


   

methyl (2r)-2-[(1r,2s)-1-[(s)-cyano(phenyl)methoxy]-2-hydroxy-3-methoxy-3-oxopropoxy]-3-hydroxypropanoate

methyl (2r)-2-[(1r,2s)-1-[(s)-cyano(phenyl)methoxy]-2-hydroxy-3-methoxy-3-oxopropoxy]-3-hydroxypropanoate

C16H19NO8 (353.1111)


   

10-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8-trien-12-one

10-{2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8-trien-12-one

C19H15NO6 (353.0899)


   

4-hydroxy-5,17-dimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,9,14(18),15-heptaene-12,13-dione

4-hydroxy-5,17-dimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,9,14(18),15-heptaene-12,13-dione

C19H15NO6 (353.0899)


   

5-{6-hydroxy-2h-pyrido[3,4-b]indole-1-carbonyl}-1,3-dimethyl-4-(methylsulfanyl)imidazol-1-ium

5-{6-hydroxy-2h-pyrido[3,4-b]indole-1-carbonyl}-1,3-dimethyl-4-(methylsulfanyl)imidazol-1-ium

[C18H17N4O2S]+ (353.1072)


   

4,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-3-yl acetate

4,5-dihydroxy-2-[4-(isothiocyanatomethyl)phenoxy]-6-methyloxan-3-yl acetate

C16H19NO6S (353.0933)


   

(3s,4r,6r,10s)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,13,15,17(21)-hexaene-4,6,13-triol

(3s,4r,6r,10s)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,13,15,17(21)-hexaene-4,6,13-triol

C18H15N3O3S (353.0834)


   

(3r,4r,5r,6r,10s)-4,6-dihydroxy-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaen-13-one

(3r,4r,5r,6r,10s)-4,6-dihydroxy-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaen-13-one

C18H15N3O3S (353.0834)


   

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2(10),3,8,15,20,22-heptaene-3,14-diol

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2(10),3,8,15,20,22-heptaene-3,14-diol

C19H15NO6 (353.0899)


   

(2s,3s)-15-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

(2s,3s)-15-bromo-7-oxa-5-thia-8,18-diazatetracyclo[9.7.0.0²,⁸.0¹²,¹⁷]octadeca-1(11),12,14,16-tetraen-3-amine

C14H16BrN3OS (353.0197)


   

methyl (2r)-2-[(1r,2s)-1-[(r)-cyano(phenyl)methoxy]-2-hydroxy-3-methoxy-3-oxopropoxy]-3-hydroxypropanoate

methyl (2r)-2-[(1r,2s)-1-[(r)-cyano(phenyl)methoxy]-2-hydroxy-3-methoxy-3-oxopropoxy]-3-hydroxypropanoate

C16H19NO8 (353.1111)